oral corticosteroids

DRUG13 trials

Sponsors

Hoffmann-La Roche, University Hospital, Montpellier, Biogen, Connecticut Children's Medical Center, NYU Langone Health

Conditions

AsthmaBell PalsyChronic Intracranial Subdural HematomaCorticosteroidDermatitis AtopicEosinophilic Chronic Rhinosinusitis With Nasal PolypsLupus NephritisNeuromyelitis Optica Spectrum Disorder

Early Phase 1

Effect of Adjuvant Hyperbaric Oxygen Therapy on Bells Palsy Outcome

WithdrawnNCT03457025

NYU Langone HealthBell Palsy

Start: 2019-08-31End: 2020-06-30Updated: 2020-05-29

Phase 2

BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis

TerminatedNCT01499355

BiogenLupus Nephritis

Start: 2012-07-31End: 2015-12-31Updated: 2017-01-18

BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis

TerminatedNCT01930890

BiogenLupus Nephritis

Start: 2013-11-30End: 2016-01-31Updated: 2017-01-18

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

Enrolling by invitationNCT05492578

SanofiDermatitis Atopic

Start: 2022-08-22End: 2029-01-22Target: 1663Updated: 2026-03-19

Phase 3

An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies

CompletedNCT00720798

Hoffmann-La RocheRheumatoid Arthritis

Start: 2005-09-30End: 2013-04-30Updated: 2014-09-30

Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas

TerminatedNCT01380028

University Hospital, MontpellierChronic Intracranial Subdural Hematoma

Start: 2011-07-22End: 2014-09-12Updated: 2021-12-28

A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

CompletedNCT02046603

Hoffmann-La RocheRheumatoid Arthritis

Start: 2014-03-04End: 2016-08-04Updated: 2018-12-07

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

CompletedNCT04660539

Hoffmann-La RocheNeuromyelitis Optica Spectrum Disorder

Start: 2021-03-02End: 2024-05-28Updated: 2024-12-27

Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

Active, not recruitingNCT05345171

Ultragenyx Pharmaceutical IncOTC Deficiency

Start: 2022-10-18End: 2031-03-01Target: 32Updated: 2026-02-17

Phase 4

Predicting Response to Standardized Pediatric Colitis Therapy

CompletedNCT01536535

Connecticut Children's Medical CenterUlcerative Colitis

Start: 2012-07-10End: 2018-04-30Updated: 2019-09-20

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

CompletedNCT02537691

Hoffmann-La RocheAsthma

Start: 2015-08-28End: 2017-07-10Updated: 2019-04-09

Unknown Phase

The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma

Joon Young ChoiAsthma, Corticosteroid

Start: 2023-03-01End: 2023-12-31Target: 800000Updated: 2023-03-06

Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial

RecruitingNCT07498374

Tang-Du HospitalEosinophilic Chronic Rhinosinusitis With Nasal Polyps

Start: 2026-01-21End: 2028-12-31Target: 192Updated: 2026-03-27

Related Papers

Interim Safety Results of Amlitelimab (anti-OX40 ligand antibody) in Participants With Moderate-to-Severe Atopic Dermatitis From the RIVER-AD Phase 2/3 Ongoing Open-Label Study

SKIN The Journal of Cutaneous Medicine2025-11-10

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

2025-07-311 citations

Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data.

2025-04-191 citations

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance.

2024-07-165 citations

Long-term Efficacy of Satralizumab in Adults with Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon (S5.001)

Neurology2023-04-251 citations

Long-term Safety of Satralizumab in Adults with Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon (P13-5.002)

Neurology2023-04-25

A retrograde approach for liver gene transfer

Molecular Therapy — Methods & Clinical Development2022-11-251 citations

Corticosteroids as an Adjuvant Treatment to Surgery in Chronic Subdural Hematomas: A Multi-Center Double-Blind Randomized Placebo-Controlled Trial

Journal of Neurotrauma2021-03-3113 citations

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study

UNC Libraries2020-09-23

Longitudinal non‐adherence predicts treatment escalation in paediatric ulcerative colitis

Alimentary Pharmacology & Therapeutics2019-08-0216 citations

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.

2019-03-29124 citations

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study

Rheumatology Advances in Practice2019-01-0110 citations

Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis

Lara D. Veeken2018-11-2110 citations

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

Lara D. Veeken2017-10-3137 citations

Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.

2017-09-2062 citations

Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study.

2016-12-0126 citations

Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.

2016-05-0545 citations

Assessing biomarkers in a real-world severe asthma study (ARIETTA).

2016-04-1415 citations